Contributions of ToleranceTove
User contributions·15 logged edits·page 1 of 1
Contributions by ToleranceTove, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,199 edits includes activity predating the current log.
- 10:35, 6 May 2026 (diff | hist) Talk:SURMOUNT trial programme 537 +180 /* Tolerability at larger effect */ new section
- 14:20, 9 Apr 2026 (diff | hist) Talk:Gastric emptying 748 +203 /* Tachyphylaxis wording */ reply
- 07:29, 28 Mar 2026 (diff | hist) Shenzhen Hybio Pharmaceutical 17,496 ±0 add the research-use-only statement to the lead rather than only the footer
- 03:58, 27 Feb 2026 (diff | hist) Wuhan Wansheng Biotechnology 15,849 ±0 de-orphan
- 01:36, 7 Feb 2026 (diff | hist) Sangon Biotech 14,764 ±0 rm the price; supplier articles carry no price per PP:VN
- 13:45, 25 Jan 2026 (diff | hist) Talk:Dose escalation schedule 611 +121 /* Selective adaptation */ reply
- 01:56, 25 Jan 2026 (diff | hist) Trifluoroacetate counterion 5,116 ±0 m clarify that mass spectrometry confirms identity, not purity
- 09:23, 23 Jan 2026 (diff | hist) Missed dose 5,277 ±0 m add the sharps-disposal cross-link
- 11:43, 20 Oct 2025 (diff | hist) Hypoglycaemia 4,473 ±0 expand §In the context of this wiki
- 23:11, 17 Jul 2025 (diff | hist) Chinese Peptide Company 13,089 ±0 m add short description
- 11:56, 27 Feb 2025 (diff | hist) Lyophilisation 17,642 ±0 add the shelf temperature and the primary drying step to the cycle description
- 10:28, 25 Jan 2025 (diff | hist) STEP trial programme 4,357 +293 correct the baseline mean — transposed digits
- 10:13, 7 Dec 2024 (diff | hist) Weight regain after discontinuation 3,536 +597 correct the percentage — source reports it per patient-year
- 20:19, 23 Oct 2024 (diff | hist) Weight regain after discontinuation 2,822 +30 m convert the adverse-event list to a table with both arms
- 15:16, 14 Aug 2024 (diff | hist) Medutest 2,091 ±0 give the fields a compendially-complete certificate would carry